MEDA, CLAUDIA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 600
EU - Europa 312
AS - Asia 228
AF - Africa 8
OC - Oceania 3
SA - Sud America 3
Totale 1.154
Nazione #
US - Stati Uniti d'America 595
CN - Cina 110
IT - Italia 57
IE - Irlanda 53
SE - Svezia 51
FI - Finlandia 28
JP - Giappone 28
DE - Germania 24
KR - Corea 24
FR - Francia 22
GB - Regno Unito 22
SG - Singapore 19
UA - Ucraina 19
IN - India 13
BE - Belgio 12
PL - Polonia 12
VN - Vietnam 12
TH - Thailandia 8
SN - Senegal 6
ID - Indonesia 3
PH - Filippine 3
BR - Brasile 2
CA - Canada 2
CH - Svizzera 2
EG - Egitto 2
ES - Italia 2
IQ - Iraq 2
IR - Iran 2
MX - Messico 2
NL - Olanda 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AU - Australia 1
CL - Cile 1
CU - Cuba 1
DK - Danimarca 1
HK - Hong Kong 1
MD - Moldavia 1
PK - Pakistan 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.154
Città #
Chandler 97
Ann Arbor 62
Beijing 53
Dublin 53
Houston 37
Fairfield 30
Nyköping 28
Dearborn 25
Torino 20
Jacksonville 19
Ashburn 18
Princeton 18
Villeurbanne 16
Medford 14
Woodbridge 13
Wilmington 11
Brussels 10
Cambridge 10
Redwood City 10
Singapore 10
Warsaw 10
Fremont 9
Seattle 8
Xian 7
Boston 6
Changsha 6
Guangzhou 6
Hefei 6
Menlo Park 6
Milan 6
Ogaki 6
Boardman 5
Fuzhou 4
Pisa 4
Créteil 3
Dong Ket 3
Formia 3
Fukuoka 3
Los Angeles 3
Naples 3
Norwalk 3
Patna 3
Tokyo 3
Al Hillah 2
Auckland 2
Davao City 2
Ghent 2
Guri-si 2
Hangzhou 2
Ho Chi Minh City 2
Hyderabad 2
Jakarta 2
Nanjing 2
New York 2
Padova 2
Parma 2
Recife 2
San Diego 2
San Francisco 2
Shanghai 2
Alexandria 1
Amsterdam 1
Bang Phae 1
Bangkok 1
Chisinau 1
Chongqing 1
Chungnam 1
Copenhagen 1
Dundee 1
Dung 1
Düsseldorf 1
Falls Church 1
Garza García 1
Guangdong 1
Guiyang 1
Gurgaon 1
Hanoi 1
Helsinki 1
Horia 1
Islamabad 1
Jinan 1
Kraków 1
Kunming 1
La Habana 1
Luni 1
Maastricht 1
Madero 1
Madiun 1
Madrid 1
Manchester 1
Miami 1
Mississauga 1
Nanchang 1
Nanning 1
Nottingham 1
Nürnberg 1
Pabianice 1
Pamplona 1
Phitsanulok 1
Phoenix 1
Totale 744
Nome #
Regulation of HMGCoA reductase Activity by Policosanol and Octacosadienol, a New synthetic Analogue of Octacosanol 259
Effect of inhibiting the sterol biosynthesis pathway and the cholesterol content in the regulation of angiogenesis in vitro and in vivo 111
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 100
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 89
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 86
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 78
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 78
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 75
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 65
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 62
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 57
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 57
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models 55
Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front 30
Totale 1.202
Categoria #
all - tutte 3.573
article - articoli 0
book - libri 0
conference - conferenze 1.932
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.505


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020175 3 5 6 21 17 43 28 10 13 12 12 5
2020/2021136 16 17 4 2 15 16 5 4 14 12 12 19
2021/2022170 9 2 5 8 6 17 4 10 8 18 53 30
2022/2023280 22 29 6 28 20 78 21 17 30 10 14 5
2023/2024116 21 34 7 7 11 4 4 3 2 8 2 13
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.202